Matrix metalloproteinase 12 (MMP-12) expression in human monocyte-derived macrophages is enhanced by exposure to cigarette smoke and is resistant to suppression by dexamethasone Source: Eur Respir J 2004; 24: Suppl. 48, 107s Year: 2004
Effect of recombinant α-1 antitrypsin (rAAT) and TAPI on neutrophil elastase (NE) and matrix metalloproteinase-9 (MMP9) activity in induced sputum (IS) from healthy smokers and patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2003 - Progress on therapy for chronic obstructive pulmonary disease Year: 2003
Matrix metalloproteinase (MMP)-2 production by fibroblasts and mast cells: the role in pulmonary fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 455s Year: 2004
Impact of acute exposure to tobacco smoke on gelatinases in the bronchoalveolar space Source: Eur Respir J 2008; 32: 644-650 Year: 2008
Effects of keratinocyte growth factor (KGF) on matrix metalloproteinases (MMPs) & tissue inhibitors of metalloproteinases (TIMPs) mRNA levels in emphysematous rats lungs Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008
Increased matrix metalloproteinase-9 concentration and activity after stimulation with interleukin-17A in mouse airways Source: Annual Congress 2004 - Insights into asthma and COPD Year: 2004
CCL5 (RANTES) inhibits TGF-β1-induced collagen production in human bronchial epithelial cells by action of Smad protein Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases Year: 2009
Pneumolysin induces release of matrix metalloproteinase-8 and -9 from human neutrophils Source: Eur Respir J 2009; 34: 1167-1170 Year: 2009
Overexpression of matrix metalloproteinase-8 and -9 in bronchiectatic airways in vivo Source: Eur Respir J 2002; 20: 170-176 Year: 2002
Exocytosis of matrix metalloproteinases (MMPs) by pulmonary and systemic polymorphonuclear neutrophils (PMN) in hospital acquired pneumonia (HAP) Source: Eur Respir J 2002; 20: Suppl. 38, 585s Year: 2002
IgA inhibits LPS-induced IL-10 in human alveolar macrophages (HAM) Source: Eur Respir J 2005; 26: Suppl. 49, 585s Year: 2005
Matrix metalloproteinase inhibitor regulates inflammatory cells migration through reducing ICAM-1 and VCAM-1 expression in a murine model of toluene diisocyanate-induced asthma Source: Eur Respir J 2003; 22: Suppl. 45, 483s Year: 2003
Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxin-exposed alveolar macrophages (AM) in COPD Source: Annual Congress 2011 - Experimental modulation of airway inflammation Year: 2011
Statins inhibit matrix metalloproteinase release from human lung fibroblasts Source: Eur Respir J 2010; 35: 637-646 Year: 2010
Cilomilast, a second generation phosphodiestease 4 inhibitor, in combination with PGE2 attenuates fMLP, IL-8 and cigarette smoke-induced effects on the mechanical and functional properties of neutrophils Source: Eur Respir J 2001; 18: Suppl. 33, 161s Year: 2001
Resveratrol impairs cytokine release from human airway smooth muscle cells (HASMCs) and alveolar macrophages (AM) in COPD Source: Annual Congress 2009 - Models of chronic airways disease and therapy Year: 2009
Activation of E-prostanoid4 and E-prostanoid2 receptors inhibits TNF-α release from human alveolar macrophages Source: Eur Respir J 2007; 29: 986-994 Year: 2007
Secretory leukoprotease inhibitor (SLPI) is removed from media of primary bronchial epithelial cells (PBEC) in the presence of neutrophil elastase (NE) Source: Eur Respir J 2005; 26: Suppl. 49, 554s Year: 2005
Effects of PDE4 inhibitors on eotaxin-3 (CCL26) expression in lung epithelial cells Source: Annual Congress 2009 - Epithelial cell biology Year: 2009